serine/threonine Kinase 17b (STK17B) Kits ELISA

over-expression causes apoptosis-like cell death which is dependent on the kinase activity [RGD, Feb 2006].. De plus, nous expédions serine/threonine Kinase 17b Anticorps (106) et serine/threonine Kinase 17b Protéines (9) et beaucoup plus de produits pour cette protéine.

list all ELISA KIts Gène GeneID UniProt
STK17B 9262 O94768
STK17B 170904 Q91XS8
STK17B 98267 Q8BG48
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top serine/threonine Kinase 17b Kits ELISA sur anticorps-enligne.fr

Showing 3 out of 4 products:

Catalogue No. Reactivité Sensibilité Gamme Images Quantité Livraison Prix Détails
Humain
  96 Tests 2 to 3 Days
$713.90
Détails
Souris
  96 Tests 16 to 26 Days
$618.29
Détails
Rat
  96 Tests 16 to 26 Days
$618.29
Détails

Plus Kits ELISA pour serine/threonine Kinase 17b partenaires d'interaction

Human serine/threonine Kinase 17b (STK17B) interaction partners

  1. STK17B promotes carcinogenesis and metastasis via AKT/GSK-3beta/Snail signaling in hepatocellular carcinoma.

  2. A significant interaction between variants in STK17B and PAX8, in papillary thyroid cancer susceptibility, is reported.

  3. ChIP assays showed that in U937 cells MYB binds to a conserved element upstream of the DRAK2 transcription start site.

  4. DRAK2 protein directly binds to the type I TGF-beta receptor and Knockdown of DRAK2 suppresses the tumorigenic ability of breast cancer cells.

  5. DRAK2 and protein kinase D form a novel signaling module that controls calcium homeostasis following T cell activation.

  6. DRAK2 kinase activity is regulated in a calcium-dependent manner and that Ser(12) phosphorylation is necessary for optimal suppression of T cell activation by this kinase

  7. Strong suppression of T cell receptor signals during thymic selection caused by ectopic DRAK2 expression in a DRAK2 transgenic mouse model of autoimmune encephalomyelitis alters the responsiveness of peripheral T cells.

  8. Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer.

Mouse (Murine) serine/threonine Kinase 17b (STK17B) interaction partners

  1. Data provide insight into the role of Drak2 in autoimmune diseases by showing that Drak2 may not suppress TGF-beta signaling in T cells, and therefore may contribute to autoimmune disease via other molecular pathways.

  2. does not function as an essential tumor suppressor or tumor surveillance protein

  3. results demonstrate that DRAK2 plays an important role in primary and memory T cell responsiveness to allografts

  4. DRAK2 and protein kinase D form a novel signaling module that controls calcium homeostasis following T cell activation.

  5. T cells from Drak2(-/-) mice exhibited enhanced sensitivity to T cell receptor-mediated stimulation with a reduced requirement for costimulation

  6. DRAK2 transduces non-apoptotic signals during thymocyte differentiation.

  7. Drak2 expresses in the T cell compartment but is not T cell-specific; it plays critical roles in T cell apoptosis and memory T cell development

  8. DRAK2 kinase activity is regulated in a calcium-dependent manner and that Ser(12) phosphorylation is necessary for optimal suppression of T cell activation by this kinase

  9. DRAK2 may be a novel target for stimulating protective immunity to viral pathogens

  10. DRAK2 may have a role in regulating the GC reaction and the response to thymus-dependent antigens, and DRAK2-deficiency is not involved in regulating intrinsic B-cell apoptosis.

  11. reduced viral load in the brains of Drak2(-/-) mice

  12. Drak2 overexpression led to aggravated beta-cell apoptosis triggered by free fatty acids (FFA) by compromising the increase of anti-apoptotic factors, such as Bcl-2, Bcl-xL and Flip, upon FFA assault

  13. Drak2 regulates the survival of activated T cells and is required for organ-specific autoimmune disease

  14. DRAK2 blockade may lead to permanent autoimmune T cell destruction via intrinsic apoptosis pathways.

  15. p70S6 kinase was a bona fide Drak2 substrate

serine/threonine Kinase 17b (STK17B) profil antigène

Antigen Summary

over-expression causes apoptosis-like cell death which is dependent on the kinase activity

Gene names and symbols associated with STK17B

  • serine/threonine kinase 17b (apoptosis-inducing) (stk17b) anticorps
  • serine/threonine kinase 17b (STK17B) anticorps
  • serine/threonine kinase 17b (Stk17b) anticorps
  • serine/threonine kinase 17b (apoptosis-inducing) (Stk17b) anticorps
  • 3110009A03Rik anticorps
  • AI120141 anticorps
  • Drak2 anticorps
  • STK17B anticorps
  • zgc:65989 anticorps

Protein level used designations for STK17B

serine/threonine-protein kinase 17B , serine/threonine kinase 17b (apoptosis-inducing) , serine/threonine kinase 17b , serine/threonine kinase 17B , serine/threonine-protein kinase 17B-like , DAP kinase-related apoptosis-inducing protein kinase 2 , death-associated protein kinase-related 2

GENE ID SPECIES
393507 Danio rerio
424049 Gallus gallus
459843 Pan troglodytes
488453 Canis lupus familiaris
511373 Bos taurus
696908 Macaca mulatta
100347229 Oryctolagus cuniculus
100410573 Callithrix jacchus
100442984 Pongo abelii
100469412 Ailuropoda melanoleuca
9262 Homo sapiens
170904 Rattus norvegicus
98267 Mus musculus
Fournisseurs de qualité sélectionnés pour serine/threonine Kinase 17b (STK17B) Kits ELISA
Avez-vous cherché autre chose?